Citadel Advisors’s Vicore Pharma Holding VCRE Stock Holding History
Bought
Maintained
Sold
Other funds holding VCRE
Citadel Advisors's VCRE Position: Q3 2026 in Review
Citadel Advisors opened a new position in Vicore Pharma Holding (VCRE) in Q3 2026: 12,654 shares worth $120K. The stake represents ﹤0.01% of the portfolio and ranks #12766 among its holdings.
5 funds tracked by Wall St. Rank hold VCRE as of Q3 2026.
- Citadel Advisors held 12,654 shares of Vicore Pharma Holding worth $120K as of Q3 2026.
- Vicore Pharma Holding was a new Citadel Advisors position in Q3 2026.
- Vicore Pharma Holding made up ﹤0.01% of Citadel Advisors's portfolio in Q3 2026, its #12766 holding.
- 5 funds tracked by Wall St. Rank held Vicore Pharma Holding as of Q3 2026.
Based on Citadel Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.